In accordance with this hypothesis, the administration of CN was observed to once again reduce AChE activity in the two brain regions under study, thereby preventing the decline in ACh that was evident in the vehicle-treated 3xTg-AD mice. This evidence concerns the gene ACHE and Alzheimer disease.